First human test: scientists check safety of new drug

NCT ID NCT03230487

Summary

This was an early-stage study to check the safety and see how the body processes a new drug called BI 1015550. It involved 42 healthy male volunteers. Researchers gave participants single and then multiple doses to monitor for side effects and measure how long the drug stayed in their system.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • CRS Clinical Research Services Mannheim GmbH

    Mannheim, 68167, Germany

Conditions

Explore the condition pages connected to this study.